Skip to Main Content
our new site.
NLM Technical Bulletin
Full Text View
No Study Results Posted
Direct Antibiotic Delivery of Cefazolin Into Soft Tissue Infections Using Subcutaneous Injection and Ultrasonic Dispersion (DAD)
Expanded access is currently available for this treatment.
Verified March 2014
by Silberg, Barry N., M.D.
Study NCT01238276 Information provided by Silberg, Barry N., M.D.
First Received on November 8, 2010. Last Updated on April 1, 2014
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Infection, Soft Tissue
Foot Ulcer, Diabetes
Additional conditions recognized in this trial
Soft Tissue Infections
More general conditions related to this trial
Connective Tissue Diseases
Endocrine System Diseases
Glucose Metabolism Disorders
Skin Diseases, Infectious
Wounds and Injuries
Interventions listed in this trial
Silberg Tissue Preparation System
Additional drug interventions recognized in this trial
More general drug interventions related to this trial
Sponsors listed in this trial
Silberg, Barry N., M.D.
Back to top of Main Content
Contact Help Desk
Lister Hill National Center for Biomedical Communications
U.S. National Library of Medicine
U.S. National Institutes of Health
U.S. Department of Health & Human Services
Freedom of Information Act
Links to all studies - primarily for crawlers